SCHEMBL7673765

SCHEMBL7673765

CC(C)(C)OC(=O)CNS(=O)(=O)c1ccc(NC(=O)/C=C/c2ccccc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
EGFR P00533 7/20 0.51
MMP1 P03956 6/20 0.51
MMP2 P08253 6/20 0.51
MMP9 P14780 6/20 0.51
TOP2A P11388 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
MAPT P10636 2/20 0.49
DEGS1 O15121 1/20 0.49
TP53 P04637 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TRPV1 Q8NER1 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
NAMPT P43490 1/20 0.47
KDM4E B2RXH2 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673769 1.00 MEN1 (0.52) MEN1KMT2AEGFRMMP1MMP2
SCHEMBL4832364 0.84 MMP1 (0.60) MEN1KMT2AEGFRMMP1MMP2
SCHEMBL4832357 0.84 MMP1 (0.60) MEN1KMT2AEGFRMMP1MMP2
SCHEMBL7669640 0.83 GHSR (0.53) MEN1KMT2AMAPTTP53CA1
SCHEMBL7582747 0.81 LMNA (0.65) MEN1KMT2AMMP2MMP9SMN1; SMN2
SCHEMBL28588397 0.80 ALDH1A1 (0.51) MEN1KMT2AMMP1MMP2MMP9
SCHEMBL7667889 0.79 PRMT1 (0.57) MEN1KMT2AMAPTSMN1; SMN2CA1
SCHEMBL7671582 0.79 ALDH1A1 (0.50) MEN1KMT2AMAPTTP53KDM4E
SCHEMBL7663139 0.79 POLB (0.62) MEN1KMT2AMMP1MMP2MMP9
SCHEMBL7663740 0.79 ALDH1A1 (0.65) MEN1KMT2ASMN1; SMN2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed